Related Experiment Video
Updated: Jul 3, 2026

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Compensatory brain activation for recognition memory in patients with medication-resistant epilepsy
James C Eliassen1, Scott K Holland, Jerzy P Szaflarski
1Center for Imaging Research, Cincinnati Epilepsy Center, University of Cincinnati Academic Health Center, Cincinnati, OH 45267-0525, USA.
Chronic epilepsy impacts verbal memory, with brain scans revealing distinct activation patterns in patients versus controls. These differences suggest compensatory mechanisms in the epilepsy group during memory tasks.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Medical Imaging
Background:
- Chronic epilepsy is associated with progressive memory decline.
- Epileptiform discharges, seizures, and medications may affect memory encoding and retrieval.
Purpose of the Study:
- To investigate the effects of chronic epilepsy on verbal recognition memory using functional MRI (fMRI).
Main Methods:
- fMRI scans were acquired from 12 patients with medication-resistant epilepsy and 18 healthy controls.
- A word recognition task was used, requiring participants to identify previously learned words.
Main Results:
- Similar fMRI activation patterns were observed in memory-related areas between groups.
- Significant differences in activation were found in the right insula, left cuneus, and bilateral subgenual anterior cingulate cortex (ACC).
- Patients with epilepsy showed greater activation for targets versus foils in these regions, unlike controls.
Conclusions:
- Despite similar task performance, epilepsy patients exhibit altered brain activation patterns during verbal recognition memory.
- These distinct activations may indicate compensatory processes in response to chronic epilepsy-related brain injury.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Glutamate Antagonists
